← Leaderboards
Badih Joseph Elmunzer
University Of Michigan At Ann Arbor
$12,954,657
Attributed
$14,669,941
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.4M · FY2011–25$2.5M$1.9M$1.3M$625K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,669,941 · 4
By mechanism
U01$13,806,590 · 2
R21$438,208 · 1
U34$425,143 · 1
Top collaborators
- John E Pandolfino1 shared
- Jacob Schauer1 shared
- Michael F Vaezi1 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Andrew Ching-Hung Chang$3,515,085
- Wendy L Wahl$550,280
- Parth Kiran Modi$74,086
Others in their field
Top investigators on “Reporting”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Jeffrey P Krischer · University Of South Florida$564,567,727
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Bambra Strokes · Ppd Development Lp$461,655,950
- Mitchell J Malone · Texas A&M Research Foundation$344,583,004
- Gary D Acton · University Of California-Davis$320,373,312
Research focus
ReportingRandomizedProceduresMorbidity - Disease RateFuturePreventionHealth ExpendituresPancreatitisPharmaceutical PreparationsMulti-Institutional Clinical TrialRectalInflammationHealth Care CostsGrantPancreasAccountingHigh RiskIndomethacinPreventProphylacticEndoscopic Retrograde CholangiopancreatographyComplicationSecondary ToSeverities
Grant awards (12)
PREcision MEDicine In Achalasia--PREMEDIA$2,287,046
U01 · FY2025 · DK
Stent vs. Indomethacin for Preventing Post-ERCP Pancreatitis: The SVI Trial$1,499,999
U01 · FY2020 · DK · contact PI
Stent vs. Indomethacin for Preventing Post-ERCP Pancreatitis: The SVI Trial$1,770,531
U01 · FY2019 · DK · contact PI
Stent vs. Indomethacin for Preventing Post-ERCP Pancreatitis: The SVI Trial$353,963
U01 · FY2019 · DK · contact PI
Stent vs. Indomethacin for Preventing Post-ERCP Pancreatitis: The SVI Trial$1,820,476
U01 · FY2018 · DK · contact PI
Stent vs. Indomethacin for Preventing Post-ERCP Pancreatitis: The SVI Trial$548,524
U01 · FY2018 · DK · contact PI
Stent vs. Indomethacin for Preventing Post-ERCP Pancreatitis: The SVI Trial$1,825,063
U01 · FY2017 · DK · contact PI
Stent vs. Indomethacin for Preventing Post-ERCP Pancreatitis: The SVI Trial$1,814,985
U01 · FY2016 · DK · contact PI
Stent vs. Indomethacin for Preventing Post-ERCP Pancreatitis: The SVI Trial$1,886,003
U01 · FY2015 · DK · contact PI
Stent vs. indomethacin for preventing post-ERCP pancreatitis (SVI study)$425,143
U34 · FY2013 · DK · contact PI
Rectal Indomethacin to Prevent of Post-ERCP Pancreatitis in High Risk Patients$231,600
R21 · FY2012 · DK · contact PI
A Prospective, Randomized, Controlled Trial of Rectal Indomethacin in the Prevent$206,608
R21 · FY2011 · DK · contact PI